MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202527104459 A) filed by Innovent Biologics Suzhou Co. , Ltd. on October 29, 2025, for Method For Treating Psoriasis With Recombinant Interleukin 23p19 Antibody.
Inventors include Yan, Shuling; Zheng, Shirui; Cai, Chenghang; and Qian, Lei.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present invention relates to a method for preventing or treating psoriasis in an individual, the method comprises: administering an IL-23p19 antibody to an individual; administering a first dose of the IL-23p19 antibody at weeks 0, 4, and 8, respectively; and administering a second dose of the IL-23p19 antibody every 8-20 weeks thereafter, wherein the first dose is 200 mg, and the second dose is 50 mg-250 mg, preferably 100 mg-200 mg.
Disclaimer: Curated by HT Syndication.
